Skip to main content
OpenTrials
Active, Not Recruiting

NCT Number: NCT06670560

Onco-Respirology Epidemiology Based on Real-world Big Data in Respiratory Medicine

The purpose of this observational study is to understand the changes in the types of respiratory patients hospitalized in China in recent years through a multicenter retrospective clinical study, and at the same time to understand the reasons for hospitalization and the distribution of different tumor types in oncology patients, so as to provide data support and theoretical basis for the future development of China's respiratory department.

The main questions it aims to answer are

1. the trend of change of respiratory diseases in China in the past 10 years. 2. the trend of change in the causes of hospitalization of respiratory tumor patients in China in the past 10 years. 3. the trend of the proportion of each tumor in the respiratory department in China over the past 10 years.

Active, Not Recruiting

This study is active but is not currently recruiting participants.

Key information

Conditions

Respiratory Epidemiology Neoplasms

Sex eligibility

All sexes

Study type

Observational

Primary location

Chengzhi Zhou

Guangdong, Guangzhou, 510145, China

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Clinical diagnosis of Respiratory diseases Must be an inpatient

Exclusion criteria

Non-respiratory inpatients

Treatment and study plan

Primary outcomes

  1. proportion

    Time frame: 10 years

    • to explore the trend of respiratory diseases (COPD, asthma, bronchiectasis, lung infection, lung cancer, etc.) over the past 10 years in China.
    • to explore the trend of the causes of hospitalization of respiratory tumor patients (pulmonary embolism, airway stenosis, post-surgical complications, lung infection, pneumothorax, tuberculosis, etc.) in China over the past 10 years.
    • to explore the trend of the proportion of each tumor in the respiratory department (brain tumor, nasopharyngeal cancer, thyroid cancer, lung cancer, breast cancer, liver cancer, etc.) over the past 10 years in China.

Sponsors and collaborators

Lead sponsor

Zhou Chengzhi

Other

Registry information

Important dates

Study start
2024
Primary completion
2026
Study completion
2026
First posted
Nov 1, 2024
Registry last updated
Nov 7, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.